Wuller Benjamin MIles sold $4.7M of RYAN

Wuller Benjamin MIles (CEO RSUM) sold 100,000 shares of RYAN SPECIALTY HOLDINGS, INC. (RYAN) at an average of $47.25 ($47.18–$47.31, $4.72M total) across 2 trades over 2026-11-09 to 2026-11-10.

Original reporting
SEC EDGAR · Wuller Benjamin MIles
Published Nov 12, 2026, 10:31 PM UTC
Analysis
AlphAI AI DeskAI-generated
Added to AlphAI Nov 12, 2026, 10:34 PM UTC. Informational, not investment advice.
How this was made
AlphAI summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
AlphAI market briefInsider activity
Primary signal
$RYAN
Bearish
medium confidence
Mentioned
$RYAN
Relevance
6/10
AlphAI data visualization · based on SEC EDGAR
Decision brief

The 30-second read

$RYANBearishLow
01

Why it matters

The transaction reduces insider ownership and may be interpreted as a negative signal, potentially prompting short‑term price pressure.

02

Market read

The filing provides fresh, material information about insider ownership that could affect short‑term trading decisions for RYAN.

03

What to watch

Potential upcoming corporate actions or financing needs that prompted the sale are not disclosed.

Relevance 6/10Novelty 4/10Timing: after-hours filing on 2026-11-12

Background

Form 4 filings disclose insider transactions; this filing reports a CEO‑initiated open‑market sale.

Company-level read

Ticker impact

$RYANBearishMedium confidence
Context

CEO Wuller Benjamin Miles sold 100,000 shares for $4.7M, reducing his stake to 94,095 shares.

Expected impact

likely pressure as the market prices in the insider sell

Evidence & confidence

A $4.7M sale by the chief executive is material for a mid‑cap stock and often triggers short‑term selling pressure.

Market effects

Minimal; the sale is company‑specific and does not affect the broader specialty holdings sector.

None; the filing is U.S.‑focused and does not influence regional markets.

Low; only relevant to investors in RYAN.

Counterpoint

The sale could be a routine liquidity event unrelated to fundamentals, so the stock may remain stable.

Key entities

  • Wuller Benjamin Miles

    CEO of RYAN Specialty Holdings, Inc.

  • RYAN Specialty Holdings, Inc.

    Publicly traded specialty holdings company (ticker RYAN).

Full insider trading history

This story covers one filing. See everything behind it: every insider buy and sell on record, 10b5-1 plans, late filings, and which officers and directors are trading.

Related articles

$RYANMed

Ryan Specialty Holdings Inc (RYAN) (Q3 2026) Earnings Call Highlights: Revenue Growth

Ryan Specialty Holdings (RYAN) reported Q3 2026 revenue growth slowing to 4% from 15% YoY, with adjusted EBITDAC margin down 30 bps to 30.9%. The company cited market challenges, including property pricing declines and increased competition. Management expects continued pressure in Q4 2026 and 2027, with modest margin expansion anticipated. They also discussed growth opportunities in reinsurance and AI-related risks, and potential M&A activity in 2027.

Med

Ryan Specialty grows revenue as property softening squeezes E&S returns

Ryan Specialty reported a 4.7% revenue increase to $790M in Q3 2026, driven by casualty lines, while property revenue declined. Underwriting management grew 5.4%, expanding its share of total revenue. Expenses rose 9.9%, outpacing revenue growth. The company maintained its full-year guidance for mid-single-digit organic revenue growth and reported a 3.8% increase in adjusted EBITDAC to $244.4M.